(2R,A-2-ALPHA-R)-4-BENZYL-[1-[3,5-BIS-(TRIFLUOROMETHYL)-PHENYL]-ETHOXY]-1,4-OXAZIN-3-ONE
Compound with spectra: 1 NMR
![(2R,A-2-ALPHA-R)-4-BENZYL-[1-[3,5-BIS-(TRIFLUOROMETHYL)-PHENYL]-ETHOXY]-1,4-OXAZIN-3-ONE](/api/compound/7R4IZSRC7hV.png?ph=true&h=300&w=458 "(2R,A-2-ALPHA-R)-4-BENZYL-[1-[3,5-BIS-(TRIFLUOROMETHYL)-PHENYL]-ETHOXY]-1,4-OXAZIN-3-ONE")
| SpectraBase Compound ID | 7R4IZSRC7hV |
|---|---|
| InChI | InChI=1S/C21H19F6NO3/c1-13(15-9-16(20(22,23)24)11-17(10-15)21(25,26)27)31-19-18(29)28(7-8-30-19)12-14-5-3-2-4-6-14/h2-6,9-11,13,19H,7-8,12H2,1H3/t13-,19+/m1/s1 |
| InChIKey | KVPJNHLVRGUYGQ-YJYMSZOUSA-N |
| Mol Weight | 447.38 g/mol |
| Molecular Formula | C21H19F6NO3 |
| Exact Mass | 447.126912 g/mol |
| Enantiomer InChIKey | KVPJNHLVRGUYGQ-ORAYPTAESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
DWCCMKXSGCKMJF-UHFFFAOYSA-N
[2(1'R),4R,5R]-4,5-Dicyclohexyl-2-[1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-1,3,2-dioxaborolane
1-BENZYL-1,2-DIHYDRO-2-OXO-N-[m-(TRIFLUOROMETHYL)BENZYL]NICOTINAMIDE
2-Allylamino-N-benzyl-N-(2,2-diethoxyethyl)benzamide
(R)-3-(3,5-bis(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroquinoline
1,2-DIHYDRO-2-OXO-1-[m-(TRIFLUOROMETHYL)BENZYL]NICOTINIC ACID, METHYL ESTER
1-[3-(DIMETHYLAMINO)-2-THENOYL]-2-[(alpha,alpha,alpha,alpha',alpha',alpha'-HEXAFLUORO-3,5-XYLYL)SULFONYL]HYDRAZINE
1-(3'-trifluoromethylphenyl)-1,2-bis(trifluoroacetoxy)-2-methylethane
N,N-dibenzyl-5-oxo-1-phenyl-3-pyrrolidinecarboxamide
Acetate, [1,1-dimethyl-2-oxo-2-(1,2,3,4-tetrahydro-2-isoquinolinyl)ethyl]ester
| Title | Journal or Book | Year |
|---|---|---|
| Efficient Synthesis of NK1 Receptor Antagonist Aprepitant Using a Crystallization-Induced Diastereoselective Transformation | Journal of the American Chemical Society | 2003 |